GlassScriptPhysician profile
James R Headrick
NPI 1104812817
$45,857.00
in general payments reported to CMS, 2019-2025
24 companies · $1,164 in 2025
The $1,164 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $112 · 2021: $2,191 · 2022: $32K · 2023: $10K · 2024: $323 · 2025: $1,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $2,950 · Consulting Fee: $1,860 · Food and Beverage: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $2,949.71 |
| Consulting Fee | $1,860.00 |
| Food and Beverage | $961.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,837.76 | 2019-2025 | Da Vinci Surgical System, Ion |
| Astrazeneca Uk Limited | $16,222.76 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $2,244.72 | 2021-2025 | Imfinzi, Tagrisso |
| Genentech USA, INC. | $1,935.26 | 2022-2025 | Tecentriq |
| Medtronic, INC. | $1,645.79 | 2021-2025 | Ligasure, Signia |
| Atricure, INC. | $251.63 | 2019-2024 | |
| Ethicon US, LLC | $124.96 | 2019-2023 | Echelon Endopath, Echelon Flex |
| Galvanize Therapeutics, INC | $73.30 | 2024 | Aliya System |
| C. R. Bard, INC. & Subsidiaries | $56.95 | 2023-2024 | |
| Caris Mpi, INC. | $54.07 | 2025 | Mi Cancer Seek |
| Tempus Ai, INC | $53.42 | 2024 | Xt Cdx |
| Merck Sharp & Dohme LLC | $52.85 | 2023-2025 | Keytruda |
| Daiichi Sankyo INC. | $47.04 | 2020-2021 | |
| Pulmonx Corporation | $41.15 | 2019 | |
| Ethicon INC. | $39.98 | 2024-2025 | Monarch Platform |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $34.46 | 2022-2023 | Endoeye Flex Deflectable Videoscope |
| Amgen INC. | $24.57 | 2022 | |
| Organogenesis INC. | $21.62 | 2021 | |
| Siemens Medical Solutions USA, INC. | $19.03 | 2020 | |
| On Target Laboratories, INC | $18.36 | 2025 | Cytalux |
| Grifols USA, LLC | $17.40 | 2020 | |
| Kls-Martin L.P. | $14.33 | 2022 | |
| Sanara Medtech INC. | $13.52 | 2023 | Celleraterx |
| Davol INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Headrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.